Who has invested in Aculys Pharma?

SoftBank Vision Fund 2 are named among the investors backing Aculys Pharma.

Aculys Pharma Funding: $140M Raised, Series C (2025)

Aculys Pharma funding overview

Aculys Pharma is based in Fujisawa, Japan. Aculys Pharma has raised $140M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2025. The round record for Aculys Pharma runs through 2025; nothing later has been disclosed. Investors on record include SoftBank Vision Fund 2.

Aculys Pharma at a glance

Total raised: $140M
Latest round: Series C
Latest round date: March 2025
Headquarters: Fujisawa, Japan
Notable investors: SoftBank Vision Fund 2

Frequently asked about Aculys Pharma funding

How much has Aculys Pharma raised?: Aculys Pharma has raised $140M in total disclosed funding across the rounds on record.
Who has invested in Aculys Pharma?: SoftBank Vision Fund 2 are named among the investors backing Aculys Pharma.
What was the latest Aculys Pharma funding round?: The most recent disclosed round is a Series C, announced in March 2025.
Where is Aculys Pharma based?: Aculys Pharma is based in Fujisawa, Japan.
When did Aculys Pharma last raise?: The last disclosed Aculys Pharma round closed in March 2025 at Series C.

Aculys Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Fujisawa below to benchmark round size and investor mix.

Aculys Pharma Funding: $140M Raised, Series C (2025)

Aculys Pharma funding overview

Aculys Pharma at a glance

Frequently asked about Aculys Pharma funding

Companies related to Aculys Pharma (19)

Browse related funding lists (3)